FirstEnergy Corp (NYSE:FE) (The Motley Fool)
What happened: Shares of First Energy (NYSE:FE) spiked on Monday and were up 15% at 10:45 a.m. EST after the utility announced that investors would pump $2.5 billion of equity into the company. So what: First Energy announced that a group of prominent investors, including Singapore’s sovereign wealth fund, will invest $2.5 billion into the company. The investment includes $1.62 billion in mandatory convertable preferred equity and $850 million in shares. The utility plans to use the cash infusion to reduce debt, contribute to its pension fund, and fund investments.
Halliburton Company (NYSE:HAL) (TheStreet)
Halliburton Co. (HAL) stock jumped on Monday, Jan. 22, after the oilfield service company reported better-than-expected earnings for its fourth quarter and issued an upbeat outlook for 2018. Shares of Halliburton rose by 3.8% to $55.04 at 10:15 a.m. EST on Monday. The Houston-based company posted a loss of $824 million for the period. Adjusted earnings of 53 cents per share beat analysts’ estimates of 46 cents per share.
lassedesignen/Shutterstock.com
Wynn Resorts, Limited (NASDAQ:WYNN) (Seeking Alpha)
Wynn Resorts (NASDAQ:WYNN) reports a 30% jump in Q4 revenue to $1.69B. The big gain was tied largely to the $248M brought in from Wynn Palace during the quarter. The casino operator saw adjusted property EBITDA increase 41% to $480.2M, with Wynn Macau tallying $186M and Wynn Palace $190M. Revenue from Las Vegas operations fell 1.6% to $377M and adjusted EBITDA was down 9% to $104M on some early quarter traffic weakness tied to the mass shooting event.
Archer Daniels Midland Co (NYSE:ADM) (CNBC)
Archer Daniels Midland – The grain processor is proposing a buyout of agricultural commodities supplier Bunge, according to The Wall Street Journal and Reuters. Bunge – which has also drawn interest from Swiss agriculture company Glencore – is said to be keeping its options open. Glencore is prevented from making a new offer for Bunge until next month, stemming from a previous standstill agreement.
Juno Therapeutics Inc (NASDAQ:JUNO) (The Motley Fool)
What happened: In response to accepting a buyout offer, shares of Juno Therapeutics (NASDAQ:JUNO), a clinical-stage biotech focused on immunotherapies, jumped 27% as of10:30 a.m. EST on Monday. So what: It appears that the rumor was true. Investors learned on Monday that Juno accepted an all-cash buyout offer from biotech giant Celgene (NASDAQ:CELG).
Validus Holdings, Ltd. (NYSE:VR) (Benzinga)
Validus Holdings, Ltd. shares jumped 44.4 percent to $67.48 after American International Group Inc AIG 0.9% announced plans to acquire Validus for $68 per share in cash.
Novavax, Inc. (NASDAQ:NVAX) (Madison.com)
What happened: Shares of Novavax (NASDAQ: NVAX), a clinical-stage synthetic vaccine specialist, jumped by as much as 21% on heavy volume in early morning trading today. What’s up? Novavax’s shares appear to be responding positively to the news that the ongoing flu season has turned into one of the worst, and most deadly, in more than a decade.
Array Biopharma Inc (NASDAQ:ARRY) (Benzinga)
Array Biopharma Inc shares gained 15.3 percent to $15.15. Array BioPharma disclosed that combination of encorafenib, binimetinib and cetuximab demonstrated an 8 month median progression-free survival in BRAF-mutant colorectal cancer in updated safety lead-in results from BEACON Phase 3 trial.
Bioverativ Inc (NASDAQ:BIVV) (CNBC)
Bioverativ – Bioverative is soaring in premarket trading after the U.S. hemophilia treatment specialist agreed to be bought by French drugmaker Sanofi for $11.6 billion in cash, or $105 per share.
